Total liabilities · 2015–2025
AstraZeneca total liabilities
$65.4B+3.5% · FY2025
AstraZeneca (AZN) reported $65.4B in total liabilities for fiscal 2025, +3.5% year on year.
| Fiscal year | Total liabilities | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $65.4B | +3.5% | Open → |
| FY20242024-12-31 | $63.2B | +2.0% | Open → |
| FY20232023-12-31 | $62.0B | +4.3% | Open → |
| FY20222022-12-31 | $59.4B | −10.1% | Open → |
| FY20212021-12-31 | $66.1B | +29.3% | Open → |
| FY20202020-12-31 | $51.1B | +9.2% | Open → |
| FY20192019-12-31 | $46.8B | +0.4% | Open → |
| FY20182018-12-31 | $46.6B | −0.2% | Open → |
| FY20172017-12-31 | $46.7B | +1.9% | Open → |
| FY20162016-12-31 | $45.9B | +10.4% | Open → |
| FY20152015-12-31 | $41.5B | — | Open → |
Total liabilities — Total liabilities is everything the company owes at the balance-sheet date — debt, payables, deferred revenue and provisions together. Where a filer does not tag it, we calculate it as total assets minus total equity and label the figure as calculated.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2015–2025 compound annual growth +4.6%
Figures are reported under IFRS, in US dollars.
Total liabilities at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=AstraZeneca total liabilities |url=https://companiesranked.com/en/company/astrazeneca/total-liabilities |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). AstraZeneca total liabilities. CompaniesRanked. https://companiesranked.com/en/company/astrazeneca/total-liabilitiesBibTeX
@misc{companiesranked-en-company-astrazeneca-total-liabilities-2026,
author = {{CompaniesRanked}},
title = {{AstraZeneca total liabilities}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/astrazeneca/total-liabilities}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001104659-26-019130 · February 24, 2026
{{cite web |title=AstraZeneca total liabilities — 20-F (0001104659-26-019130) |url=https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/azn-20251231x20f.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-24}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.